BioSpace News Archive

LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate’s Advisory Board, will assume the role of Chairman of the Board.

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that it presented new data on the therapeutic potential of its lead anti-miR candidate for the treatment of glioblastoma multiforme (GBM),

Merck KGaA Darmstadt, Germany, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy.

An inventor from Upper Marlboro, Md., has developed the AlertIV, a modified IV device that will provide a visual indication of a problem, including improper placement or the need to replace.

PharmScript, a leading pharmacy provider to long-term care and post-acute care facilities, today announced the acquisition of Doehring’s LTC Pharmacy.

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) (“Axonics”), today announced that the underwriters of its initial public offering exercised in full their option to purchase an additional 1,200,000 shares of common stock from Axonics at the initial public offering price of $15.00 per share, less underwriting discounts and commissions.

TraceLink Inc., the world’s largest integrated digital supply network, providing real-time information sharing for better patient outcomes, today announced financial and company results for the third quarter of 2018.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced a collaboration with Obsidian Therapeutics to provide semi-mechanistic models and analysis services.

Attitudes and Abilities Significantly Improve After Brief Instruction, According to Journal of the American Osteopathic Association

The spin-off from the Leibniz-Institute for New Materials (INM) in Saarbrücken, Nano-Care Deutschland AG launches the third generation of ultra-thin coatings: “wipe-on glass” provides any kind of hard surface with a self-disinfecting performance for a period of several months, to several years.